Is there evidence of brain white-matter abnormalities in obsessive-compulsive disorder? A narrative review

Topics in Magnetic Resonance Imaging

Volumn 20, Issue 5, 2009, Pages 291-298

  Fontenelle, Leonardo F ^a,b,c   Harrison, Ben J ^a   Yücel, Murat ^a   Pujol, Jesus ^d   Fujiwara, Hironobu ^a   Pantelis, Christos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d Barcelona Biomedical Research Park   (Spain)

Author keywords

diffusion tensor imaging; magnetic resonance imaging; obsessive compulsive disorder; spectroscopy; white matter

Indexed keywords

ANXIOLYTIC AGENT; CITALOPRAM; CREATINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; PSYCHOTROPIC AGENT; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT DISEASE; ARTICLE; BRAIN CORTEX; BRAIN DISEASE; BRAIN FUNCTION; BRAIN LEVEL; BRAIN REGION; CAPSULA INTERNA; CASE STUDY; CEREBROVASCULAR DISEASE; CHILDHOOD DISEASE; CINGULATE GYRUS; CORPUS CALLOSUM; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; FRACTIONAL ANISOTROPY; GENETIC HETEROGENEITY; HUMAN; LEUKOENCEPHALOPATHY; MEDICAL LITERATURE; MEDLINE; MORPHOMETRICS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOM; TREATMENT RESPONSE; WHITE MATTER;

BRAIN; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; NEURONS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 77957368263     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e3181e8f22c     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32:525-549.
3. Harrison BJ, Soriano-Mas C, Pujol J, et al. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry. 2009;66:1189-1200.
4. Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 2000;28:343-347.
5. Miguel EC, Stein MC, Rauch SL, et al. Obsessive-compulsive disorder in patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 1995;7:507-510.
6. Douzenis A, Michalopoulou PG, Voumvourakis C, et al. Obsessive-compulsive disorder associated with parietal white matter multiple sclerosis plaques. World J Biol Psychiatry. 2009;10:956-960.
7. Bovier P, Lovey M, Tissot R. Apropos of a probable case of Binswanger encephalopathy [in French]. Schweiz Arch Neurol Psychiatr. 1989;140:337-343.
8. Lawrence RM. Is the finding of obsessional behaviour relevant to the differential diagnosis of vascular dementia of the Binswanger type? Behav Neurol. 2000;12:149-154.
9. Swoboda KJ, Jenike MA. Frontal abnormalities in a patient with obsessive-compulsive disorder: the role of structural lesions in obsessive-compulsive behavior. Neurology. 1995;45:2130-2134.
10. Muehlschlegel S, Okun MS, Foote KD, et al. Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Mov Disord. 2005;20:1523-1527.
11. Laplane D, Levasseur M, Pillon B, et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain. 1989;112:699-725.
12. Garber HJ, Ananth JV, Chiu LC, et al. Nuclear magnetic resonance study of obsessive-compulsive disorder. Am J Psychiatry. 1989;146: 1001-1005.
13. Breiter HC, Filipek PA, Kennedy DN, et al. Retrocallosal white matter abnormalities in patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:663-664.
14. Jenike MA, Breiter HC, Baer L, et al. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry. 1996;53:625-632.
15. Duran FL, Hoexter MQ, Valente AA Jr, et al. Association between symptom severity and internal capsule volume in obsessive-compulsive disorder. Neurosci Lett. 2009;452:68-71.
16. Koprivová J, Horácek J, Tintera J, et al. Medial frontal and dorsal cortical morphometric abnormalities are related to obsessive-compulsive disorder. Neurosci Lett. 2009;464:62-66.
17. van den Heuvel OA, Remijnse PL, Mataix-Cols D, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain. 2009;132:853-868.
18. Jin Lee K, Wook Shin Y, Wee H, et al. Gray matter volume reduction in obsessive-compulsive disorder with schizotypal personality trait. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1146-1149.
19. Riffkin J, Yücel M, Maruff P, et al. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res. 2005;138: 99-113.
20. Atmaca M, Yildirim H, Ozdemir H, et al. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:46-52.
21. Atmaca M, Yildirim BH, Ozdemir BH, et al. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1051-1057.
22. Zalesky A, Fornito A, Harding IH, et al. Whole-brain anatomical networks: does the choice of nodes matter? Neuroimage. 2010;50:970-983.
23. Pantelis C, Yücel M, Bora E, et al. Neurobiological markers of illness onset in psychosis and schizophrenia: the search for a moving target. Neuropsychol Rev. 2009;19:385-398.
24. Testa R, Pantelis C. The role of executive functions in psychiatric disorders. In: Wood SJ, Allen N, Pantelis C, eds. The Neuropsychology of Mental Illness. Cambridge, UK: Cambridge University Press; 2010:117-137.
25. Pujol J, Soriano-Mas C, Alonso P, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61:720-730.
26. Di X, Chan RC, Gong QY. White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: an activation likelihood estimation meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1390-1394.
27. Frydman I, Ferreira-Garcia R, Borges MC, et al. Dementia developing in late-onset and treatment-refractory obsessive-compulsive disorder. Cogn Behav Neurol. In press.
28. Szeszko PR, MacMillan S, McMeniman M, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry. 2004;161:1049-1056.
29. Carmona S, Bassas N, Rovira M, et al. Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study. Neurosci Lett. 2007;421:218-223.
30. MacMaster F, Vora A, Easter P, et al. Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder. Psychiatry Res. 2010;181:97-100.
31. Rosenberg DR, Keshavan MS, Dick EL,etal. Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1269-1283.
32. MacMaster FP, Keshavan MS, Dick EL, et al. Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:601-612.
33. Lázaro L, Bargalló N, Castro-Fornieles J, et al. Brain changes in children and adolescents with obsessive-compulsive disorder before and after treatment: a voxel-based morphometric MRI study. Psychiatry Res. 2009;172:140-146.
34. Kitamura H, Shioiri T, Kimura T, et al. Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-tesla. Acta Psychiatr Scand. 2006;114:101-108.
35. Jang JH, Kwon JS, Jang DP, et al. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am J Psychiatry. 2006;163:1202-1207.
36. Whiteside SP, Port JD, Deacon BJ, et al. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006;146:137-147.
37. White T, Nelson M, Lim KO. Diffusion tensor imaging in psychiatric disorders. Top Magn Reson Imaging. 2008;19:97-109.
38. Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci. 2008;34:51-61.
39. Basser PJ, Pierpaoli C. A simplified method to measure the diffusion tensor from seven MR images. Magn Reson Med. 1998;39:928-934.
40. Pierpaoli C, Jezzard P, Basser PJ, et al. Diffusion tensor MR imaging of the human brain. Radiology. 1996;201:637-648.
41. Szeszko PR, Ardekani BA, Ashtari M, et al. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry. 2005;62:782-790. (Pubitemid 41002761)
42. Cannistraro PA, Makris N, Howard JD, et al. A diffusion tensor imaging study of white matter in obsessive-compulsive disorder. Depress Anxiety. 2007;24:440-446.
43. Saito Y, Nobuhara K, Okugawa G, et al. Corpus callosum in patients with obsessive-compulsive disorder: diffusion-tensor imaging study. Radiology. 2008;246:536-542.
44. Nakamae T, Narumoto J, Shibata K, et al. Alteration of fractional anisotropy and apparent diffusion coefficient in obsessive-compulsive disorder: a diffusion tensor imaging study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1221-1226.
45. Garibotto V, Scifo P, Gorini A, et al. Disorganization of anatomical connectivity in obsessive compulsive disorder: a multi-parameter diffusion tensor imaging study in a subpopulation of patients. Neurobiol Dis. 2010;37:468-476.
46. Ha TH, Kang DH, Park JS, et al. White matter alterations in male patients with obsessive-compulsive disorder. Neuroreport. 2009;20: 735-739.
47. Menzies L, Williams GB, Chamberlain SR, et al. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry. 2008;165:1308-1315.
48. Yoo SY, Jang JH, Shin YW, et al. White matter abnormalities in drug-naïve patients with obsessive-compulsive disorder: a diffusion tensor study before and after citalopram treatment. Acta Psychiatr Scand. 2007;116:211-219.
49. Yücel M, Wood SJ, Wellard RM, et al. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust N Z J Psychiatry. 2008;42:467-477.
50. Yücel M, Harrison BJ, Wood SJ, et al. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry. 2007;64:946-955.
51. Kochunov P, Glahn DC, Lancaster JL, et al. Genetics of microstructure of cerebral white matter using diffusion tensor imaging. Neuroimage. In press.
52. Stewart SE, Platko J, Fagerness J, et al. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry. 2007;64:209-214.
53. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31:1487-1505.
54. Seal ML, YücelM,FornitoA,et al. Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity. Schizophrenia Research. 2008;101:106-110.